About Curology
Curology provides personalized skincare solutions through an online platform. Clients start by completing a questionnaire and uploading photos of their skin, which allows Curology's dermatology providers to create a custom skincare formula tailored to their specific needs. This product is then shipped directly to the client's home. Curology stands out from competitors by focusing on individual skin concerns and offering ongoing support from dermatology professionals, making it particularly appealing to those who have struggled with traditional skincare products. The company operates on a subscription model, with a monthly fee that includes the custom formula and access to dermatological advice, as well as a trial option for new clients.
San Francisco, CaliforniaHeadquarters
2014Year Founded
$18.3MTotal Funding
SERIES_BCompany Stage
Consumer Software, Consumer GoodsIndustries
201-500Employees
Benefits
PTO + Paid parental leave
Equity
Free Curology subscription
Health, dental, and vision insurance
Employee donation matching
401k plan
Flexible spending plans
Commuter benefits
Expensed educational courses
Risks
Increased competition from other personalized skincare brands may impact Curology's market share.
Expansion into hair care could divert focus from core skincare offerings, affecting quality.
Amazon partnership may lead to pricing pressures and reduced profit margins.
Differentiation
Curology offers personalized skincare with prescription formulas delivered directly to customers' doors.
The company provides virtual consultations with dermatology providers for customized skincare solutions.
Curology's subscription model includes ongoing dermatological support and custom skincare formulas.
Upsides
Curology's expansion into hair care taps into a growing market for personalized treatments.
Partnership with Amazon increases accessibility and distribution of Curology's skincare products.
Rising demand for personalized skincare aligns with Curology's direct-to-consumer business model.
Funding
Total raised$18.29 M
Latest valuation$75.00 M
StageSERIES_B
SERIES B
7/31/2016$15
$75.00 MSERIES A
11/30/2014$4
$19.00 M